
Imlunestrant Alone or With Verzenios Improved PROs in Advanced Breast Cancer
Imlunestrant alone or in combination with Verzenios (abemaciclib) improved patient-reported outcomes among those with with estrogen receptor (ER)–positive, HER2-negative advanced breast cancer who progressed after endocrine therapy. Notably, these data …